The influence of polymorphisms of fat mass and obesity (FTO, rs9939609) and vitamin D receptor (VDR, BsmI, TaqI, ApaI, FokI) genes on weight loss by diet and exercise interventions in non-diabetic overweight/obese Asian Indians in North India.


Journal

European journal of clinical nutrition
ISSN: 1476-5640
Titre abrégé: Eur J Clin Nutr
Pays: England
ID NLM: 8804070

Informations de publication

Date de publication:
04 2020
Historique:
received: 17 07 2019
accepted: 14 01 2020
revised: 09 01 2020
pubmed: 1 2 2020
medline: 25 6 2021
entrez: 1 2 2020
Statut: ppublish

Résumé

The aim of the present study was to evaluate polymorphisms of fat mass and obesity (FTO; rs9939609) and vitamin D receptor (VDR, FokI (rs2228570), BsmI (rs1544410), ApaI (rs7975232), and TaqI (rs731236)] genes on weight loss after lifestyle interventions in Asian Indians. In this 6-month pre-post intervention trial, 110 overweight/obese men and women underwent diet and exercise interventions for 180 days resulting in reduction in body weight, (5.1 kg, p < 0.001), waist circumference, and skinfolds. Association of the following genotypes was seen in those with ≥5% weight loss: TT of FTO polymorphism; 35 (81.4%) [OR (95% CI) AT, 2.5 (0.6, 10.9); TT, 6.9 (1.6, 28.2); with reference to AA], tt of VDR TaqI polymorphism, 12 (92.3%) [OR (95% CI); tt, 32.2 (2.4, 436.4); TT, 0.5 (0.08, 3.1); all with reference to Tt], bb of VDR BsmI polymorphism; 27 (65.8%) [OR (95% CI) Bb, 0.2 (0.04, 0.9); bb, 10.6 (0.9, 120.3); all with reference to BB] after adjusting for other genotypes. Further, analysis of combined influence of genotypes conferring maximum weight loss showed that the following had high odds of ≥5% weight loss: (1) TT of FTO gene in combination with BB/Bb of VDR BsmI and TT/Tt of VDR TaqI [OR (95% CI) 5.1 (1.5, 17.4)], (2) bb of BsmI and AA/AT of FTO and tt of TaqI [OR (95% CI) 3.2 (0.3, 31.7)], and (3) bb of BsmI plus TT of FTO and tt of TaqI. The above observations suggest a significant and independent role of the genotypes of FTO and VDR in influencing weight loss after lifestyle intervention in Asian Indians.

Identifiants

pubmed: 32001813
doi: 10.1038/s41430-020-0560-4
pii: 10.1038/s41430-020-0560-4
doi:

Substances chimiques

Receptors, Calcitriol 0
VDR protein, human 0
Alpha-Ketoglutarate-Dependent Dioxygenase FTO EC 1.14.11.33
FTO protein, human EC 1.14.11.33

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

604-612

Subventions

Organisme : Indian Council of Medical Research (ICMR)
ID : 5/4/8-/9/2011-NCD-II
Pays : International

Références

Hills AP, Misra A, Gill JMR, Byrne NM, Soares MJ, Ramachandran A, et al. Public health and health systems: implications for the prevention and management of type 2 diabetes in south Asia. Lancet Diabetes Endocrinol. 2018;6:992–1002.
pubmed: 30287104
Maes HHM, Neale MC, Eaves LJ. Genetic and environmental factors in relative body weight and human adiposity. Behav Genet. 1997;27:325–51.
pubmed: 9519560
Stunkard AJ, Foch TT, Hrubec Z. A twin study of human obesity. J Am Med Assoc. 1986;256:51.
Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518:197–206.
pubmed: 25673413 pmcid: 4382211
Yeo GS. The role of the FTO (fat mass and obesity related) locus in regulating body size and composition. Mol Cell Endocrinol. 2014;397:34–41.
pubmed: 25224490
Loos RJ, Lindgren CM, Li S, Wheeler E, Zhao JH, Prokopenko I, et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet. 2008;40:768–75.
pubmed: 18454148 pmcid: 2669167
Liu CT, Young KL, Brody JA, Olden M, Wojczynski MK, Heard-Costa N, et al. Sequence variation in TMEM18 in association with body mass index: Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Targeted Sequencing Study. Circ Cardiovasc Genet. 2014;7:344–9.
pubmed: 24951660 pmcid: 4135723
Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316:889–94.
pubmed: 17434869 pmcid: 2646098
Filus A, Trzmiel A, Kuliczkowska-Plaksej J, Tworowska U, Jedrzejuk D, Milewicz A, et al. Relationship between vitamin D receptor BsmI and FokI polymorphisms and anthropometric and biochemical parameters describing metabolic syndrome. Aging Male. 2008;11:134–9.
pubmed: 18821289
Naito M, Miyaki K, Naito T, Zhang L, Hoshi K, Hara A, et al. Association between vitamin D receptor gene haplotypes and chronic periodontitis among Japanese men. Int J Med Sci. 2007 ;4:216–22.
pubmed: 17848979 pmcid: 1975778
Grundberg E, Brandstrom H, Ribom EL, Ljunggren O, Mallmin H, Kindmark A. Genetic variation in the human vitamin D receptor is associated with muscle strength, fat mass and body weight in Swedish women. Eur J Endocrinol. 2004;150:323–8.
pubmed: 15012617
Jain R, von Hurst PR, Stonehouse W, Love DR, Higgins CM, Coad J. Association of vitamin D receptor gene polymorphisms with insulin resistance and response to vitamin D. Metabolism. 2012;61:293–301.
pubmed: 21871642
Oh JY, Barrett-Connor E. Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study. Metabolism. 2002;51:356–9.
pubmed: 11887173
Ananthakrishnan N, Shanthi AK. ICMR’s ethical guidelines for biomedical research on human participants: need for clarification. Indian J Med Ethics. 2012;9:207–9.
pubmed: 22864084
Misra A, Chowbey P, Makkar BM, Vikram NK, Wasir JS, Chadha D, et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India. 2009;57:163–70.
pubmed: 19582986
Misra A, Sharma R, Gulati S, Joshi SR, Sharma V, Ghafoorunissa, et al. Consensus dietary guidelines for healthy living and prevention of obesity, the metabolic syndrome, diabetes, and related disorders in Asian Indians. Diabetes Technol Ther. 2011;13:683–94.
pubmed: 21488798
Gulati S, Misra A, Tiwari R, Sharma M, Pandey RM, Yadav CP. Effect of high-protein meal replacement on weight and cardiometabolic profile in overweight/obese Asian Indians in North India. Br J Nutr. 2017;117:1531–40.
pubmed: 28653586
Vikram NK, Misra A, Pandey RM, Dwivedi M, Luthra K. Adiponectin, insulin resistance, and C-reactive protein in postpubertal Asian Indian adolescents. Metabolism. 2004;53:1336–41.
pubmed: 15375791
Misra A, Anoop S, Gulati S, Mani K, Bhatt SP, Pandey RM. Body fat patterning, hepatic fat and pancreatic volume of non-obese Asian Indians with type 2 diabetes in North India: a case-control study. PLoS ONE. 2015;10:e0140447.
pubmed: 26474415 pmcid: 4608569
Ye WZ, Reis AF, Dubois-Laforgue D, Bellanne-Chantelot C, Timsit J, Velho G. Vitamin D polymorphisms are associated with obesity in type 2 diabetic subjects with early age of onset. Eur J Endocrinol. 2001;145:181.
pubmed: 11454514
Vasilopoulos Y, Sarafidou T, Kotsa K, Papadimitriou M, Goutzelas Y, Stamatis C, et al. VDR TaqI is associated with obesity in the Greek population. Gene. 2013;512:237–9.
pubmed: 23103831
Hitman GA, Mannan N, McDermott MF, Aganna E, Ogunkolade BW, Hales C, et al. Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians. Diabetes. 1998;47:688.
pubmed: 9568705
Livingstone KM, Celis-Morales C, Papandonatos GD, Erar B, Florez JC, Jablonski KA. et al. FTO genotype and weight loss: systematic review andmeta-analysis of 9563 individual participant data from eight randomised controlled trials. BMJ. 2016;354:i4707.
pubmed: 27650503 pmcid: 6168036
Perusse L, Bouchard C. Gene-diet interactions in obesity. Am J Clin Nutr. 2000;72(5 Suppl):1285S–90S.
pubmed: 11063470
Gerken T, Girard CA, Tung YC, Webby CJ, Saudek V, Hewitson KS. et al. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependentnucleic acid demethylase. Science. 2007;318:1469–72.
pubmed: 17991826 pmcid: 2668859
Blumberg JM, Tzameli I, Astapova I, Lam FS, Flier JS, Hollenberg AN. et al. Complex role of the vitamin D receptor and its ligand in adipogenesis in 3T3-L1 cells. JBiol Chem. 2006;218:11205.
Wardle J, Carnell S, Haworth CM, Farooqi IS, O’Rahilly S, Plomin R. Obesity associated genetic variation in FTO is associated with diminished satiety. J Clin Endocrinol Metab. 2008;93:3640–3.
pubmed: 18583465
Hinney A, Nguyen TT, Scherag A, Friedel S, Bronner G, Muller TD, et al. Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants. PLoS ONE 2007;2:e1361.
pubmed: 18159244 pmcid: 2137937
Speakman JR, Rance KA, Johnstone AM. Polymorphisms of the FTO gene are associated with variation in energy intake, but not energy expenditure. Obesity. 2008;16:1961–5.
pubmed: 18551109
Cecil JE, Tavendale R, Watt P, Hetherington MM, Palmer CN. An obesity-associated FTO gene variant and increased energy intake in children. N. Engl J Med. 2008;359:2558–66.
pubmed: 19073975
Prakash J, Mittal B, Srivastava A, Awasthi S, Srivastava N. Association of FTO rs9939609 SNP with obesity and obesity-associated phenotypes in a North Indian population. Oman Med J. 2016;31:99–106.
pubmed: 27168919 pmcid: 4861386
Ursu RI, Badiu C, Cucu N, Ursu GF, Craciunescu I, Severin E. The study of the rs9939609 FTO gene polymorphism in association with obesity and the management of obesity in a Romanian cohort. J Med Life. 2015;8:232–8.
pubmed: 25866584 pmcid: 4392093
Rees SD, Islam M, Hydrie MZ, Chaudhary B, Bellary S, Hashmi S, et al. An FTO variant is associated with Type 2 diabetes in South Asian populations after accounting for body mass index and waist circumference. Diabet Med. 2011;28:673–80.
pubmed: 21294771 pmcid: 3095685
Liu Y, Liu Z, Song Y, Zhou D, Zhang D, Zhao T, et al. Meta-analysis added power to identify variants in FTO associated with type 2 diabetes and obesity in the Asian population. Obesity. 2010;18:1619–24.
pubmed: 20057365
Chauhan G, Tabassum R, Mahajan A, Dwivedi OP, Mahendran Y, Kaur I, et al. Common variants of FTO and the risk of obesity and type 2 diabetes in Indians. J Hum Genet. 2011;56:720–6.
pubmed: 21814223
Vasan SK, Karpe F, Gu HF, Brismar K, Fall CH, Ingelsson E, et al. FTO genetic variants and risk of obesity and type 2 diabetes: a meta-analysis of 28,394 Indians. Obesity. 2014;22:964–70.
pubmed: 23963770
Ranjith N, Pegoraro RJ, Shanmugam R. Obesity-associated genetic variants in young Asian Indians with the metabolic syndrome and myocardial infarction. Cardiovasc J Afr. 2011;22:25–30.
pubmed: 21298202 pmcid: 3736384
Yajnik CS, Janipalli CS, Bhaskar S, Kulkarni SR, Freathy RM, Prakash S, et al. FTO gene variants are strongly associated with type 2 diabetes in South Asian Indians. Diabetologia. 2009;52:247–52.
pubmed: 19005641
Sanghera DK, Ortega L, Han S, Singh J, Ralhan SK, Wander GS, et al. Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk. BMC Med Genet. 2008;9:59.
pubmed: 18598350 pmcid: 2481250
Ramya K, Radha V, Ghosh S, Majumder PP, Mohan V. Genetic variations in the FTO gene are associated with type 2 diabetes and obesity in south Indians (CURES-79). Diabetes Technol Ther. 2011;13:33–42.
pubmed: 21175269
Matsuo T, Nakata Y, Hotta K, Tanaka K. The FTO genotype as a useful predictor of body weight maintenance: initial data from a 5-year follow-up study. Metabolism. 2014;63:912–7.
pubmed: 24798613
Wong KE, Szeto FL, Zhang W, Ye H, Kong J, Zhang Z, et al. Involvement of the vitamin D receptor in energy metabolism: regulation of uncoupling proteins. Am J Physiol-Endocrinol Metab. 2009;296:E820.
pubmed: 19176352 pmcid: 2670625
Corella D, Qi L, Sorli JV, Godoy D, Portoles O, Coltell O, et al. Obese subjects carrying the 11482G>A polymorphism at the perilipin locus are resistant to weight loss after dietary energy restriction. J Clin Endocrinol Metab. 2005;90:5121–6.
pubmed: 15985482
Goni L, Riezu-Boj JI, Milagro FI, Corrales FJ, Ortiz L, Cuervo M, et al. Interaction between an ADCY3 genetic variant and two weight-lowering diets affecting body fatness and body composition outcomes depending on macronutrient distribution: a randomized trial. Nutrients. 2018;10:789.
Sun D, Heianza Y, Li X, Shang X, Smith SR, Bray GA, et al. Genetic, epigenetic and transcriptional variations at NFATC2IP locus with weight loss in response to diet interventions: the POUNDS lost trial. Diabetes Obes Metab. 2018;20:2298–303.
pubmed: 29693310 pmcid: 6105429
Goni L, Qi L, Cuervo M, Milagro FI, Saris WH, MacDonald IA, et al. Effect of the interaction between diet composition and the PPM1K genetic variant on insulin resistance and beta cell function markers during weight loss: results from the nutrient gene interactions in human obesity: implications for dietary guidelines (NUGENOB) randomized trial. Am J Clin Nutr. 2017;106:902–8.
pubmed: 28768654
Papandonatos GD, Pan Q, Pajewski NM, Delahanty LM, Peter I, Erar B. et al. Genetic Predisposition to Weight Loss and Regain With Lifestyle Intervention: Analyses From the Diabetes Prevention Program and the Look AHEAD Randomized Controlled Trials. Diabetes. 2015;64:4312–21.
pubmed: 26253612 pmcid: 4657576

Auteurs

Seema Gulati (S)

Diabetes Foundation, New Delhi, India.
National Diabetes, Obesity and Cholesterol Foundation (N-DOC), New Delhi, India.
Center of Nutrition & Metabolic Research (C-NET), New Delhi, India.

Anoop Misra (A)

Diabetes Foundation, New Delhi, India. anoopmisra@gmail.com.
National Diabetes, Obesity and Cholesterol Foundation (N-DOC), New Delhi, India. anoopmisra@gmail.com.
Center of Nutrition & Metabolic Research (C-NET), New Delhi, India. anoopmisra@gmail.com.
Fortis C-DOC Center for Excellence for Diabetes, Metabolic Disease and Endocrinology, New Delhi, India. anoopmisra@gmail.com.

Rajneesh Tiwari (R)

National Diabetes, Obesity and Cholesterol Foundation (N-DOC), New Delhi, India.

Meenu Sharma (M)

National Diabetes, Obesity and Cholesterol Foundation (N-DOC), New Delhi, India.

Ravindra M Pandey (RM)

All India Institute of Medical Sciences, New Delhi, India.

Ashish Datt Upadhyay (AD)

All India Institute of Medical Sciences, New Delhi, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH